Tenderfy

Suministros de Nivolumab (DOE), Ipilimumab (DOE), Fedratinib (DOE), Luspatercept (DOE), Azacitidina (DOE) y Abatacept (DOE)

Buyer
OSAKIDETZA - Servicio Vasco de Salud - Organización Central
Published
2026-11-03
Deadline
Not provided
Sources
TED
Value
56530520.58 EUR

Description

The description is in the source language.

Suministros de Nivolumab (DOE), Ipilimumab (DOE), Fedratinib (DOE), Luspatercept (DOE), Azacitidina (DOE) y Abatacept (DOE)

CPV: 33600000

Membership

Read notice previews free of charge. Official notice and document links, construction permits and personal MCP access require an active paid membership.

Read